AM-Pharma’s management team is highly experienced in drug development. The Company is also supported by an internationally-renowned Supervisory Board comprised of senior level executives associated with leading life science venture capital firms.
Erik has over seventeen years experience in the pharmaceutical and biotechnology industries. He joined AM-Pharma in September 2007 as Chief Business Officer...View Profile
Jacques has over twenty six years experience in the pharmaceutical industry, where he has held senior positions in medical and clinical development. He joined AM-Pharma in February 2008...View Profile
Steve has over thirty years management experience and extensive knowledge of the pharmaceutical and biological industries, including the management of R&D and manufacturing operations...View Profile
Peter has over 35 years experience in finance. He joined AM-Pharma in 2002. Most recently, he worked as Controller for Glaucus Proteomics, a Dutch biotech start-up company...View Profile
Andrea has managed various discovery alliances with biotech and academia in the field of Oncology. Previously, he was Proof-of-Concept Team Leader for Schering-Plough's Immune Oncology portfolio...View Profile
Tim has 10 years of progressively responsible experience in the biotech and venture capital industries. He joined the AM-Pharma team in 2012, and is responsible for Corporate and Business Development of the company. Since 2015, he is also responsible for alliance management with Pfizer Inc.View Profile